`U.S. Patent 8,536,122
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`
`NOVO NORDISK A/S,
`Patent Owner
`______________________
`Case IPR2023-00722
`Patent 8,536,122
`______________________
`
`POWER OF ATTORNEY AND
`DESIGNATION OF LEAD AND BACK-UP COUNSEL
`
`
`
`
`
`IPR2023-00722
`U.S. Patent 8,536,122
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Patent Owner Novo Nordisk A/S, hereby
`
`appoints the following practitioners as its attorneys to transact all business in the
`
`United States Patent and Trademark Office associated with the above-captioned
`
`inter partes review, and designate their lead and back-up counsel as follows:
`
`
`
`Lead Counsel
`J. Steven Baughman (Reg. No. 47,414)
`GROOMBRIDGE, WU, BAUGHMAN
`& STONE LLP
`Washington, D.C.
`Tel.: (202)505-5832
`Steve.baughman@groombridgewu.com
`
`Backup Counsel
`Megan Raymond (Reg. No. 72,997)
`GROOMBRIDGE, WU, BAUGHMAN
`& STONE LLP
`Washington, D.C.
`Tel.: (202)505-5878
`Megan.raymond@groombridgewu.com
`
`
`
`Novo Nordisk A/S hereby appoints additional practitioners associated with
`
`Groombridge, Wu, Baughman & Stone LLP who appear in any future updated
`
`mandatory notices, and any attorneys from Groombridge, Wu, Baughman & Stone
`
`LLP admitted pro hac vice in this matter.
`
`The individual signing below has the authority to execute this document on
`
`behalf of Novo Nordisk A/S.
`
`1
`
`
`
`Dated: April 5, 2023
`
`
`
`
`
`IPR2023-00722
`U.S. Patent 8,536,122
` Respectfully submitted,
`
`By: _/s/ K. Jones_____
`Kathryn Jones
`VP, Chief Counsel IP
`
`for Patent Owner Novo Nordisk A/S
`
`
`
`CERTIFICATE OF SERVICE
`
`IPR2023-00722
`U.S. Patent 8,536,122
`
`It is certified that a copy of the following documents has been served in its
`
`entirety on the patent owner as provided in 37 CFR §42.205:
`
`The copy has been served on April 6, 2023 by causing the aforementioned
`
`document to be electronically mailed to the following attorneys of record for
`
`Petitioner listed below:
`
`Lead Counsel:
`
`Brandon M. White
`Reg. No. 52,354
`White-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`By Electronic Mail
`Backup Counsel: Emily J. Greb
`Reg. No. 68,244
`Greb-ptab@perkinscoie.com
`Perkins Coie LLP
`33 East Main Street
`Madison, WI 53703
`Telephone: (608) 663-7460
`
`Courtney Prochnow, PhD
`Reg. No. 67,639
`Prochnow-ptab@perkinscoie.com
`Perkins Coie LLP
`633 W. 5th St., Ste 5850
`Los Angeles, CA 90071
`Telephone: (310) 788-9900
`
`Christopher D. Jones
`Reg. No. 76,472
`
`1
`
`
`
`IPR2023-00722
`U.S. Patent 8,536,122
`
`Jones-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`Jonathan I. Tietz, PhD
`Reg. No. 76,753
`Tietz-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`Matthew A. Lembo
`Reg. No. 75,633
`Lembo-ptab@perkinscoie.com
`Perkins Coie LLP
`1155 Avenue of the Americas
`Floor 22
`New York, NY 10036
`Telephone: (212) 262-6900
`
`Semaglutide-Ozempic@perkinscoie.com
`By Electronic Mail
`Perkins Coie LLP
`Brandon M. White
`White-ptab@perkinscoie.com
`Emily J. Greb
`Greb-ptab@perkinscoie.com
`Courtney Prochnow, PhD
`Prochnow-ptab@perkinscoie.com
`Christopher D. Jones
`Jones-ptab@perkinscoie.com
`Jonathan I. Tietz, PhD
`Tietz-ptab@perkinscoie.com
`Matthew A. Lembo
`Lembo-ptab@perkinscoie.com
`
`Semaglutide-Ozempic@perkinscoie.com
`
`Litigation
`Address:
`
`
`
`IPR2023-00722
`U.S. Patent 8,536,122
`
`By Electronic Mail
`
`Dated: April 6, 2023
`
`
`
`
`
`
`
` Respectfully submitted,
`By: /Sayem Osman
`Sayem Osman
`
`